These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 17354539
1. [Intravitreal anti-VEGF injections improve the visual prognosis of wet age related macular degeneration]. Ambresin A, Mantel I. Rev Med Suisse; 2007 Jan 17; 3(94):137-41. PubMed ID: 17354539 [Abstract] [Full Text] [Related]
2. [The results of wet AMD treatment by intravitreal injections--preliminary report]. Okruszko A, Borucka AI, Ulińska M, Szaflik J. Klin Oczna; 2007 Jan 17; 109(10-12):389-93. PubMed ID: 18488380 [Abstract] [Full Text] [Related]
3. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab. Funk M, Karl D, Georgopoulos M, Benesch T, Sacu S, Polak K, Zlabinger GJ, Schmidt-Erfurth U. Ophthalmology; 2009 Dec 17; 116(12):2393-9. PubMed ID: 19815292 [Abstract] [Full Text] [Related]
4. [Ranibizumab for treatment of exudative age-related macular degeneration--own experience]. Wykrota H, Gierek-Lapińska A, Trzciakowski K, Gajdzik-Gajdecka U. Klin Oczna; 2007 Dec 17; 109(10-12):402-9. PubMed ID: 18488382 [Abstract] [Full Text] [Related]
5. [The treatment of the exsudative age-related macular degeneration with choroidal neovascular membrane, its possibilities and economical indexes]. Karel I. Cesk Slov Oftalmol; 2007 Sep 17; 63(5):311-9. PubMed ID: 17915581 [Abstract] [Full Text] [Related]
8. Ranibizumab for the treatment of neovascular AMD. Kaiser PK, Do DV. Int J Clin Pract; 2007 Mar 17; 61(3):501-9. PubMed ID: 17313620 [Abstract] [Full Text] [Related]
9. Intravitreal administration of the anti-tumor necrosis factor agent infliximab for neovascular age-related macular degeneration. Theodossiadis PG, Liarakos VS, Sfikakis PP, Vergados IA, Theodossiadis GP. Am J Ophthalmol; 2009 May 17; 147(5):825-30, 830.e1. PubMed ID: 19211094 [Abstract] [Full Text] [Related]
10. [Guidance for the treatment of neovascular age-related macular degeneration (AMD)]. Karska-Basta I, Kubicka-Trzaska A, Oleksy P, Romanowska-Dixon B. Przegl Lek; 2009 May 17; 66(11):972-5. PubMed ID: 20297641 [Abstract] [Full Text] [Related]
16. A value-based medicine analysis of ranibizumab for the treatment of subfoveal neovascular macular degeneration. Brown MM, Brown GC, Brown HC, Peet J. Ophthalmology; 2008 Jun 17; 115(6):1039-1045.e5. PubMed ID: 17976724 [Abstract] [Full Text] [Related]
17. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Lalwani GA, Rosenfeld PJ, Fung AE, Dubovy SR, Michels S, Feuer W, Davis JL, Flynn HW, Esquiabro M. Am J Ophthalmol; 2009 Jul 17; 148(1):43-58.e1. PubMed ID: 19376495 [Abstract] [Full Text] [Related]